Company: DHR
Filing Date: 2025-10-21
Form Type: 10-Q
Source: 0000313616-25-000182
Chunk: 157

Company: DANAHER CORP /DE/
Filing Date: 2025-10-21
Form: 10-Q
Item: Item 2
Chunk 157
---
 26, 2025 as compared to the comparable period of 2024.  

Year-to-date 2025 vs. year-to-date 2024 operating profit margin comparisons were unfavorably impacted by:

•First nine months of 2025 impairment charge related to a trade name, net of an impairment charge related to a trade name in the first nine months of 2024 - 405 basis points

•Lower 2025 core sales, the impact of product mix and the impact of changes in leverage from the segment’s operational and administrative cost structure - 205 basis points

•The incremental dilutive effect in 2025 of acquired businesses - 35 basis points

Year-to-date 2025 vs. year-to-date 2024 operating profit margin comparisons were favorably impacted by:

•First nine months of 2024 acquisition-related fair value adjustment to inventory - 45 basis points

Depreciation and amortization of intangible assets increased as a percentage of sales during both the three and nine-month periods ended September 26, 2025, primarily due to the impact of acquisitions.  

33

DIAGNOSTICS

The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.

Diagnostics Selected Financial Data

 Three-Month Period EndedNine-Month Period Ended($ in millions)September 26, 2025September 27, 2024September 26, 2025September 27, 2024Sales$2,463 $2,363 $7,221 $7,150 Operating profit665 615 1,937 2,001 Depreciation101 95 301 292 Amortization of intangible assets48 49 144 145 Operating profit as a % of sales27.0 %26.0 %26.8 %28.0 %Depreciation as a % of sales4.1 %4.0 %4.2 %4.1 %Amortization as a % of sales1.9 %2.1 %2.0 %2.0 %

Sales Growth and Core Sales Growth

% Change Three-Month Period Ended September 26, 2025 vs. Comparable 2024 Period% Change Nine-Month Period Ended September 26, 2025 vs. Comparable 2024 Period